Skip to main content

Month: July 2022

Plant-based Milk Market Size and Growth Outlook 2022-2029 | North America to Lead Stoked by Rising Adoption of Healthy Diet

Key Players Covered in the Report are DREAM, Danone, Daiya Foods, Archer Daniels Midland, Malk Organic, Ripple Foods, The New Barn, Califia Farms, Other prominent companies Pune, India, July 07, 2022 (GLOBE NEWSWIRE) — The global plant-based milk market is set to gain impetus from the increasing awareness of the numerous health benefits of coconut milk and soy milk. Fortune Business Insights™ published this information in an upcoming report, titled, “Plant-based Milk Market Size, Share & Industry Analysis, and Regional Forecast, 2019-2026.” The report further states that the persistent efforts of reputed companies to launch novel plant-based milk would affect growth positively. The COVID-19 pandemic has resulted in the closure of restaurants and bars across the globe to prevent transmission. The daily footfall in restaurants...

Continue reading

Enservco Corporation Reports 2021 Fourth Quarter and Full Year Financial Results

Q4 revenue up 71% YOY as Company posts gains across all service offerings based on increased customer activity driven by higher commodity pricesThird consecutive quarter of double-digit YOY revenue growth following pandemic and drilling downturn that began in second quarter of 2020Balance sheet recently strengthened through refinancing of bank debtGrowth momentum carries into 2022 with first quarter revenue expected to increase between 58% and 64% YOYCompany working to complete 2022 first and second quarter Form 10-Qs and will conduct earnings conference call at that time to address all recent resultsLONGMONT, Colo., July 07, 2022 (GLOBE NEWSWIRE) — Enservco Corporation (NYSE American: ENSV), a diversified national provider of specialized well-site services to the domestic onshore conventional and unconventional...

Continue reading

Iris Energy Limited Announces Monthly Investor Update for June 2022

Figure 1 Mackenzie – medium voltage transformer placementFigure 2 Mackenzie – all major electrical equipment installed in substationFigure 3 Prince George – PDUs being installedFigure 4 Prince George – data center construction in progressFigure 5 Childress – site construction office and entranceFigure 6 Childress – site civil works ongoingChart Daily average operating hashrate chartOperating guidance increased from 3.7 EH/s to 4.3 EH/s in 2022 Mackenzie development activities progressing ahead of schedule SYDNEY, Australia, July 07, 2022 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (“Iris Energy” or “the Company”), a leading sustainable Bitcoin miner which is building an institutional-grade infrastructure platform (4.3 EH/s expected to be operational by the end of Q4 2022), today published a monthly...

Continue reading

Form 8.3 – [CARETECH HOLDINGS PLC 06 07 2022] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [EMIS GROUP PLC – 06 07 2022] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Freehold Royalties Ltd. enters into Agreements to Acquire U.S. Midland Basin and Eagle Ford Basin Assets for CAD$155 million

CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) has entered into definitive agreements with two private sellers to acquire high-quality U.S. mineral title and royalty assets located in the Midland basin predominantly in Howard County, Texas (the “Howard County Midland Assets”) for $123 million and in the Eagle Ford basin in Texas (the “Eagle Ford Assets”) for $32 million, both figures net of estimates for exchange rates and customary closing adjustments. Freehold also recently closed its previously announced $19 million acquisition of mineral title and royalty assets in the Midland basin (the “Diversified Midland Assets”) (collectively, the “U.S. Acquisitions”). All references in this news release to dollar amounts are in Canadian dollars unless otherwise indicated. The...

Continue reading

RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results

— Expects second quarter 2022 preliminary UPNEEQ net product sales of approximately $8.4 million, representing an increase of 42% from the first quarter 2022 — — Second quarter 2022 net product sales growth contributes to approximately $14.4 million in the six months ended June 30, 2022 — — Approximately 2,200 cumulative unique medical aesthetics practices placed orders for UPNEEQ through quarter-end, a 100% increase from the first quarter 2022 — — Reaffirms fourth quarter 2022 UPNEEQ net product sales guidance of $20 to $25 million — BRIDGEWATER, N.J., July 07, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced preliminary second quarter 2022 net product sales of UPNEEQ® (oxymetazoline hydrochloride...

Continue reading

Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen

This becomes the 6th Senhance Hospital in Germany RESEARCH TRIANGLE PARK, N.C., July 07, 2022 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the installation of a Senhance® Surgical System in the Department of Gynecology at the University Hospital Tübingen. The Department of Gynecology at the University Hospital Tübingen previously initiated its Senhance Surgical program in December of 2021, as announced by the Company on January 10, 2022. The system will be initially utilized by the Department of Gynecology at the University Hospital Tübingen. Independent of the lease and utilization agreement, the Department of Gynecology at the University Hospital...

Continue reading

Stantec to Release Second Quarter 2022 Results on August 10, 2022, and Host Conference Call on August 11, 2022

EDMONTON, Alberta, July 07, 2022 (GLOBE NEWSWIRE) — TSX,NYSE: STN Stantec will release its second quarter 2022 financial results after markets close on Wednesday, August 10, 2022. On Thursday, August 11, 2022, at 7:00 AM Mountain Time (9:00 AM Eastern Time), Gord Johnston, President and Chief Executive Officer, and Theresa Jang, Executive Vice President and Chief Financial Officer, will hold a conference call to discuss the Company’s performance. The webcast and slide presentation can be accessed at:https://edge.media-server.com/mmc/p/i4emhi93 The conference call and slideshow presentation will be broadcast live and archived in their entirety in the Investors section of stantec.com. Participants wishing to listen to the call via telephone may dial in toll-free at 1-888-394-8218 (Canada and United States) or 1-647-484-0475 (international)....

Continue reading

Form 8.3 – LXI Reit

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Investec Wealth & Investment Limited(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeLXI Reit PLC(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)        Date...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.